BioLineRx Ltd (BLRX):企業の財務・戦略的SWOT分析

◆英語タイトル:BioLineRx Ltd (BLRX) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH10103FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:45
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イスラエル
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥28,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥42,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

BioLineRx Ltd (BLRX) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

BioLineRx Ltd (BioLineRx) is a clinical stage biopharmaceutical company that focuses on the development of products related to cancer and immunology. Its pipeline product BL-8040 is a short peptide that is in Phase IIb clinical trial studies for acute myeloid leukemia (AML), Phase III studies for autologous transplantation and completed Phase IIa clinical trials for relapsed or refractory AML. The company’s other pipeline drug candidate AGI-134 is synthetic alpha-gal immunotherapy that finds application in the treatment of solid tumors. BioLineRx’s only product BL-5010 is a novel medical device indicated for non-surgical removal of skin lesions. BioLineRx is headquartered in Modi’in, Israel.

BioLineRx Ltd Key Recent Developments

Nov 23,2020: BioLineRx biolinerx reports third quarter 2020 financial results and provides corporate update
Aug 06,2020: BioLineRx reports second quarter 2020 financial results and provides corporate update
May 20,2020: BioLineRx reports first quarter 2020 financial results and provides corporate update
Mar 12,2020: BioLineRx reports year-end 2019 financial results and provides corporate update

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
BioLineRx Ltd – Key Facts
BioLineRx Ltd – Key Employees
BioLineRx Ltd – Key Employee Biographies
BioLineRx Ltd – Major Products and Services
BioLineRx Ltd – History
BioLineRx Ltd – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
BioLineRx Ltd – Business Description
BioLineRx Ltd – Corporate Strategy
BioLineRx Ltd – SWOT Analysis
SWOT Analysis – Overview
BioLineRx Ltd – Strengths
BioLineRx Ltd – Weaknesses
BioLineRx Ltd – Opportunities
BioLineRx Ltd – Threats
BioLineRx Ltd – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
BioLineRx Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
BioLineRx Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
BioLineRx Ltd, Recent Deals Summary
Section 5 – Company’s Recent Developments
Nov 23, 2020: BioLineRx biolinerx reports third quarter 2020 financial results and provides corporate update
Aug 06, 2020: BioLineRx reports second quarter 2020 financial results and provides corporate update
May 20, 2020: BioLineRx reports first quarter 2020 financial results and provides corporate update
Mar 12, 2020: BioLineRx reports year-end 2019 financial results and provides corporate update
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
BioLineRx Ltd, Key Facts
BioLineRx Ltd, Key Employees
BioLineRx Ltd, Key Employee Biographies
BioLineRx Ltd, Major Products and Services
BioLineRx Ltd, History
BioLineRx Ltd, Subsidiaries
BioLineRx Ltd, Key Competitors
BioLineRx Ltd, Ratios based on current share price
BioLineRx Ltd, Annual Ratios
BioLineRx Ltd, Annual Ratios (Cont...1)
BioLineRx Ltd, Interim Ratios
BioLineRx Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
BioLineRx Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
BioLineRx Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[BioLineRx Ltd (BLRX):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ContourGlobal plc (GLO):企業の財務・戦略的SWOT分析
    ContourGlobal plc (GLO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Baosteel Group Corporation:企業のM&A・事業提携・投資動向
    Baosteel Group Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Baosteel Group Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • B2W – Companhia Global Do Varejo
    B2W - Companhia Global Do Varejo - Strategy, SWOT and Corporate Finance Report Summary B2W - Companhia Global Do Varejo - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Immunicom Inc-医療機器分野:企業M&A・提携分析
    Summary Immunicom Inc (Immunicom) is a specialty biotechnology company with focus on the development of a blood filtering device for the treatment of cancer and autoimmune diseases. The company’s lead program, sTNFR Immunopheresis, is a non-drug based cancer therapy that uses a proprietary immunoads …
  • Ferguson Enterprises Inc:企業の戦略的SWOT分析
    Ferguson Enterprises Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • XOMA Corp (XOMA):製薬・医療:M&Aディール及び事業提携情報
    Summary XOMA Corp (Xoma), formerly Xoma Ltd, is a biopharmaceutical company that develops antibody-based therapeutics. Its lead product, gevokizumab is a monoclonal antibody used for the treatment of a wide variety of inflammatory diseases and other diseases. Its other pipeline products include X358 …
  • Ferrovie Dello Stato Italiane S.p.A.:企業の戦略的SWOT分析
    Ferrovie Dello Stato Italiane S.p.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • CullenFrost Bankers Inc (CFR):企業の財務・戦略的SWOT分析
    CullenFrost Bankers Inc (CFR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Yihai International Holding Ltd (1579):企業の財務・戦略的SWOT分析
    Yihai International Holding Ltd (1579) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • National Jewish Health-製薬・医療分野:企業M&A・提携分析
    Summary National Jewish Health (NJH), formerly National Jewish Medical and Research Center is a healthcare center that offers treatment of pulmonary, cardiac, immune and related disorders. The center offers services in the areas of allergy, asthma, cardiology, clinical immunology, COPD, environmenta …
  • Advanced Proteome Therapeutics Corp (APC):企業の財務・戦略的SWOT分析
    Advanced Proteome Therapeutics Corp (APC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Torm Plc (TRMD A):企業の財務・戦略的SWOT分析
    Torm Plc (TRMD A) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Cowen Inc:企業の戦略・SWOT・財務情報
    Cowen Inc - Strategy, SWOT and Corporate Finance Report Summary Cowen Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Avenue Supermarts Limited (DMART):企業の財務・戦略的SWOT分析
    Avenue Supermarts Limited (DMART) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Pentax Europe GmbH-医療機器分野:企業M&A・提携分析
    Summary Pentax Europe GmbH (Pentax Medical), a subsidiary of Hoya Corp is a medical device company that provides clinical endo-imaging solutions. The company offers products in the therapeutic areas of gastroenterology, endoscopic ultrasound, ENT and speech, pulmonology, and urology. Its products in …
  • Basic Energy Services Inc (BAS):石油・ガス:M&Aディール及び事業提携情報
    Summary Basic Energy Services Inc (Basic Energy) is an oil and gas company that offers well site services. The company’s services including well servicing, snubbing, water logistics, saltwater disposal, pumping services, coil tubing, water solutions, wireline, contract drilling, coil tubing and tubu …
  • Kewpie Corporation:戦略・SWOT・企業財務分析
    Kewpie Corporation - Strategy, SWOT and Corporate Finance Report Summary Kewpie Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Nuvaira Inc:医療機器:M&Aディール及び事業提携情報
    Summary Nuvaira Inc (Nuvaira), formerly Holaira Inc is an independent medical device company that strives to develop minimally invasive products for the treatment of obstructive lung diseases. It provides Lung Denervation System, a catheter-based system intended for asthma and chronic obstructive pu …
  • Sygnis AG (LIO1)-医療機器分野:企業M&A・提携分析
    Summary Sygnis AG (Sygnis), formerly Sygnis Pharma AG is a biopharmaceutical company that develops novel products and tools in fields of molecular biology. The company undertakes development and marketing of new molecular biological technologies for DNA amplification and sequencing. Its products inc …
  • Pegasystems Inc (PEGA):企業の財務・戦略的SWOT分析
    Pegasystems Inc (PEGA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆